P00001606T0076|37 50|5-nucleotidase
P00008171T0000|30 47|hyperbilirubinemia
P00008997A0472|4 6|CSF
P00008997A0472|7 10|HCO3
P00008997A0472|34 40|CSF PCO2
P00013683A0210|53 56|VCO2
P00013683A0210|68 78|ventilation
P00015731A0090|63 75|acetazolamide
P00015731A0090|78 90|methazolamide
P00015731A0090|92 107|dichlorphenamide
P00015731A0090|214 215|pH
P00022143T0000|20 30|etoperidone
P00029555A0861|31 42|quantitation
P00029953T0045|0 14|Characteristics
P00030183T0000|18 28|association
P00030183T0000|33 38|HLA-B5
P00030937A0119|0 3|SGPT
P00030937A0119|5 8|SGOT
P00033873T0001|27 30|GGTP
P00038408T0000|9 19|stimulation
P00038408T0000|29 47|alpha-autoreceptors
P00038408T0000|70 85|alpha-methyldopa
P00038408T0000|89 91|FLA
P00050628A0202|2 4|IgG
P00055040A0000|3 14|out-patients
P00055040A0000|70 87|immunofluorescence
P00055040A0000|157 166|FR-antigen
P00055040A0000|237 239|HPF
P00055040A0000|243 254|cryoglobulin
P00056837A0000|5 21|mediastinoscopies
P00056837A0000|74 84|operability
P00056901A0308|27 46|hydroxy-ethyl-starch
P00060529A0695|27 42|acquisition-rate
P00060529A0695|215 218|A.B.
P00061478T0000|4 16|complications
P00061478T0000|19 33|catheterisation
P00063680T0000|19 31|galactosaemia
P00066874T0000|61 73|contamination
P00072928T0000|0 13|Serum-ferritin
P00072928T0000|27 42|haemochromatosis
P00073344A0367|41 51|lymphocytes
P00074758T0000|16 29|hypothyroidism
P00086313A0000|20 31|Legionnaires
P00089778A0000|3 15|concentration
P00089778A0000|58 68|plasminogen
P00089778A0000|70 82|C3-complement
P00089778A0000|113 115|FDP
P00096241A0087|0 1|T4
P00096241A0087|5 8|FT4I
P00096241A0087|136 138|EGA
P00100540T0000|28 41|susceptibility
P00101300A0257|36 37|T1
P00101300A0257|40 41|T2
P00101300A0257|43 44|T3
P00101300A0257|46 47|N0
P00101300A0257|49 50|N1
P00105401A0635|11 13|CBZ
P00105401A0635|17 19|DPH
P00105401A0635|36 47|interference
P00105401A0635|75 77|TBG
P00105401A0635|204 206|FT4
P00105401A0635|210 212|FT3
P00105903A0288|30 40|possibility
P00105903A0288|66 68|PEG
P00112627A0542|0 12|Pentobarbital
P00112627A0542|49 59|combination
P00112627A0542|86 98|normeperidine
P00112627A0542|111 121|anileridine
P00112627A0542|132 143|alphaprodine
P00113657A0628|11 15|gcm-2
P00113657A0628|39 49|improvement
P00114144A0189|114 125|similarities
P00117748T0000|0 11|Erythromycin
P00117748T0000|38 63|Corynebacterium diphtheriae
P00118044A0000|14 26|displacements
P00118044A0000|83 84|M2
P00119339A0400|118 128|myocarditis
P00119339A0400|142 153|degeneration
P00129659T0000|0 10|Variability
P00129659T0000|31 40|trisomy-21
P00129659T0000|79 81|IQs
P00130573T0054|0 2|VII
P00131739T0001|35 45|populations
P00133214T0064|40 43|USSR
P00136175A1137|3 13|maintenance
P00136175A1137|140 150|enlargement
P00136175A1137|153 155|ECA
P00137671A0896|5 16|observations
P00137671A0896|50 59|VIII-ratio
P00139624A0318|18 31|administration
P00139827A0000|0 16|Radioimmunoassays
P00139827A0000|19 30|pregnenolone
P00139827A0000|32 43|progesterone
P00139827A0000|45 66|dehydroepiandrosterone
P00139827A0000|67 69|DHA
P00139827A0000|74 90|alpha-hydroxy-DHA
P00142718A0156|93 102|99mTc-EHDP
P00149899T0001|29 39|development
P00150066A0100|33 43|coagulation
P00154430A0906|35 46|localization
P00154430A0906|73 85|transcription
P00155973A0387|194 198|min-1
P00155973A0387|237 241|min-1
P00159600A0871|0 1|SV
P00159600A0871|17 19|SHR
P00167544A0067|25 39|microdissection
P00173860A0475|129 140|disturbances
P00173860A0475|143 153|elimination
P00176742T0000|0 10|Polyglactin
P00188387A0975|9 20|lipoproteins
P00188387A0975|75 76|FH
P00196255A0000|114 126|verbalization
P00196255A0000|176 186|bizarreness
P00198510T0000|0 10|Innervation
P00201881A0487|45 55|correlation
P00201881A0487|63 68|PI ACTH
P00205074A0000|7 22|hypophosphatemia
P00209664A0836|10 20|correlation
P00209664A0836|95 105|correlation
P00210220X0000|9 22|neurochemistry
P00211881A0602|126 128|PBB
P00219533T0001|0 11|Distribution
P00219533T0001|15 26|correlations
P00219533T0001|59 69|populations
P00219565A0172|40 50|transfusion
P00219674A0000|0 13|Technetium-99m
P00219674A0000|22 34|pyrophosphate
P00219674A0000|45 55|scintigrams
P00221725A0523|85 95|neutrophils
P00222102A0227|57 67|vitamin-D-3
P00222102A0227|157 169|normalisation
P00222102A0227|172 184|serum-calcium
P00222827A0000|11 21|sensitivity
P00222827A0000|33 44|diisocyanate
P00222827A0000|45 47|TDI
P00222827A0000|107 121|hyperreactivity
P00224013A0661|5 7|VO2
P00224013A0661|95 104|beta-Block
P00224013A0661|216 226|utilization
P00224013A0661|392 405|vasodilatation
P00225352T0000|49 50|3H
P00227393T0000|12 45|25-hydroxyvitamin D3-24-hydroxylase
P00227393T0000|48 60|aminophylline
P00227610A1593|31 37|DBP mRNA
P00227610A1593|66 69|SV40
P00231555T0001|74 77|ACTH
P00232456T0000|12 14|RNA
P00232456T0000|32 35|MC29
P00232456T0000|39 41|MH2
P00234206T0000|54 64|arboviruses
P00234264A0164|104 114|aminopyrine
P00234626T0036|0 2|XXI
P00239014A0000|38 50|determination
P00239014A0000|78 81|CPIB
P00239169T0000|30 41|neuroleptics
P00240518A0000|33 45|determination
P00300314A0132|96 110|hospitalization
P00300314A0132|173 177|mg/m2
P00300314A0132|203 214|methotrexate
P00304310A0000|3 11|end-stage
P00304310A0000|54 64|retinopathy
P00304310A0000|76 88|stabilization
P00304806A0760|107 120|concentrations
P00321261A0104|20 34|prostaglandin E2
P00321261A0104|35 38|PGE2
P00321261A0104|44 63|prostaglandin F2alpha
P00330364A0132|74 76|BCG
P00330364A0132|138 152|BCG-vaccination
P00330364A0132|183 197|BCG-vaccination
P00330364A0132|230 241|laboratories
